Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL

Conference call and webcast to be held Monday, December 7, 2020 at 4:00 pm ET / 9:00 pm GMT

LONDON, Dec. 05, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T